Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
2.
Reprod Sci ; 27(6): 1340-1349, 2020 06.
Artigo em Inglês | MEDLINE | ID: mdl-31993996

RESUMO

The aim of this study is to evaluate the effect of severe endometriosis in younger patients compared to tubal infertility on pregnancy and live birth rate undergoing in vitro fertilization (IVF). This prospective observational study included 294 women with severe endometriosis and 358 women with tubal factor as control who underwent IVF. Follicular fluid samples were collected during oocyte retrieval, and cytokines and angiogenic factors were estimated. The groups were sub-stratified based on age. Number of metaphase II oocytes, grade I/II embryos, pregnancy rate, miscarriage rate per pregnancy, and live birth rate were compared. Significantly elevated levels of cytokines and angiogenic molecules were observed in younger endometriosis patients when compared to tubal group (p < 0.001). Number of MII oocytes (p < 0.003) and grade I/II embryos (p < 0.001) were observed to be significantly lower in these women when compared with matched controls. Despite higher levels of inflammatory cytokines, angiogenic molecules, fewer MII oocytes, and grade I/II embryos, the younger endometriosis patients had similar pregnancy (OR 0.81; 95% CI 0.54-1.22; p = 0.31) and live birth rate (OR 0.78; 95% CI 0.5-1.2; p = 0.26) when compared with matched controls. In contrast, endometriosis patients of age ≥ 35 years had significantly less likelihood of live birth (OR 0.47; 95% CI 0.25-0.9; p = 0.02) and pregnancy rate (OR 0.46; 95% CI 0.22-0.95; p = 0.03), respectively, when compared with the matched controls. It appears that women with severe endometriosis have even chance of successful pregnancy if diagnosed at early age and sought for assisted reproductive technology to reduce its adverse effect on reproductive outcome.


Assuntos
Coeficiente de Natalidade , Endometriose , Fertilização in vitro , Infertilidade Feminina , Taxa de Gravidez , Adulto , Feminino , Humanos , Nascido Vivo , Indução da Ovulação , Gravidez , Estudos Retrospectivos , Adulto Jovem
3.
Reprod Biomed Online ; 38(1): 13-21, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-30446308

RESUMO

RESEARCH QUESTION: Reports on the effect of adenomyosis on assisted reproductive technology (ART) outcomes are conflicting. Does presence of adenomyosis affect reproductive outcome in IVF cycles in women pretreated with gonadotrophin releasing hormone (GnRH) agonist? DESIGN: In this retrospective cohort study, 973 women were divided into four groups: only endometriosis (n = 355); endometriosis and adenomyosis (n = 88); adenomyosis alone (n = 64); and tubal factor infertility as controls (n = 466). The pregnancy outcome parameters (clinical pregnancy, miscarriage rate, live birth rate) were compared between these groups. RESULTS: The clinical pregnancy rate was 36.62% in women with endometriosis alone, 22.72% in women with endometriosis and adenomyosis, 23.44% in women who only had adenomyosis and 34.55% in controls. Miscarriage rates were as follows: 14.62%, 35%, 40% and 13.04%, respectively. Live birth rates were 27.47% in controls; 26.48% in women with only endometriosis; 11.36% in women with endometriosis and adenomyosis; and 12.5% in women with only adenomyosis. Live birth was observed to be less in adenomyosis groups compared with controls and women with only endometriosis. No significant difference was observed in clinical pregnancy, miscarriage or live birth rate between controls and women with only endometriosis. Live birth rate was significantly different between controls and women with adenomyosis only (P = 0.01) and women with endometriosis and adenomyosis (P = 0.002). CONCLUSION: Presence of adenomyosis seems to have adverse effects on IVF outcomes in clinical pregnancy rate, live birth rate and miscarriage rate. Screening for adenomyosis might be considered before ART so that the couple has better awareness of the prognosis.


Assuntos
Adenomiose/complicações , Endometriose/complicações , Fertilização in vitro , Infertilidade Feminina/etiologia , Taxa de Gravidez , Adulto , Coeficiente de Natalidade , Feminino , Humanos , Nascido Vivo , Gravidez , Resultado da Gravidez , Estudos Retrospectivos
4.
Arch Gynecol Obstet ; 298(2): 427-432, 2018 08.
Artigo em Inglês | MEDLINE | ID: mdl-29955952

RESUMO

PURPOSE: An alternative option to human chorionic gonadotropin (hCG) is GnRH agonist (GnRH-a) for ovulation trigger in intrauterine insemination (IUI) cycles. This study aims to compare the efficacy of GnRH-a with hCG in women with history of follicular-endometrial asynchrony after clomiphene in IUI cycles. METHODS: This prospective observational study recruited 631 women with unexplained infertility and follicular-endometrial asynchrony (follicle ≥ 18 mm, endometrial thickness (ET) < 7 mm) in previous two failed clomiphene/IUI cycles. Overall 27 patients with synchronized follicular-endometrial relationship and 49 women with persistent ET < 7 mm and/or follicle > 26 mm were excluded. Remaining women (n = 555) were divided into two groups: Group A (n = 285) received GnRH-a and Group B (n = 270) received hCG ovulation trigger. Finally, 513 patients, who underwent IUI, were analysed. RESULTS: Cancellation due to luteinized unruptured follicle was more in hCG group (P = 0.01). Higher clinical pregnancies (10.33 vs. 4.96%, P = 0.03) and live birth rates (8.86 vs. 4.13%, P = 0.03) were noted with GnRH-a trigger. Miscarriage rate was comparable in both the groups (10.71 and 16.67% in Group A and Group B, respectively). CONCLUSION: In unexplained infertility, GnRH agonist is an useful alternative for triggering ovulation in women with follicular-endometrial asynchrony following clomiphene induction.


Assuntos
Clomifeno/uso terapêutico , Hormônio Liberador de Gonadotropina/uso terapêutico , Infertilidade/tratamento farmacológico , Inseminação Artificial , Indução da Ovulação/métodos , Adulto , Gonadotropina Coriônica/uso terapêutico , Endométrio/efeitos dos fármacos , Feminino , Hormônio Liberador de Gonadotropina/agonistas , Humanos , Folículo Ovariano/efeitos dos fármacos , Folículo Ovariano/crescimento & desenvolvimento , Ovulação/efeitos dos fármacos , Gravidez , Taxa de Gravidez , Estudos Prospectivos
5.
J Hum Reprod Sci ; 10(3): 235-237, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-29142455

RESUMO

Severe ovarian hyperstimulation syndrome (OHSS) is a potentially life-threatening complication of assisted reproductive technology. Herein, we report the case of an infertile couple, with the husband being azoospermic, who underwent in-vitro fertilisation and intracytoplasmic sperm injection at our institute. The woman presented with late OHSS 7 days after embryo transfer. Inpatient management was performed with intensive surveillance. Oral cabergoline was started prophylactically but was replaced by the vaginal route due to intolerance. Transvaginal paracentesis was performed five times over 20 days, and a total of 27 L of ascitic fluid was drained. The patient improved substantially and had a further uneventful pregnancy course. This case report helped us theorise that large-volume paracentesis is safe and efficacious in the management of severe OHSS. In addition, the vaginal route of cabergoline administration is more favourable than the oral route in view of lesser side effects and better patient compliance.

6.
Int J Gynaecol Obstet ; 135(2): 196-199, 2016 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-27594379

RESUMO

OBJECTIVE: To assess the efficacy of intra-amniotic administration of surfactants in reducing the incidence and severity of respiratory distress syndrome (RDS), and the need for postnatal endotracheal surfactant during preterm delivery. METHODS: A prospective pilot study enrolled pregnant women at 28-34 weeks of pregnancy between July 1, 2013 and December 31, 2014 who were randomly assigned in a 1:1 ratio to a control group or to receive intra-amniotic surfactant (3mL) administered under ultrasonography guidance within 2-8 hours of expected delivery. The primary outcomes, the incidence and severity of RDS, and the need for postnatal surfactants, were analyzed on an intention-to-treat basis. RESULTS: The study enrolled 20 patients to each group. The incidence of RDS did not differ between the two groups (P=0.110). Severe RDS was more common in the control group (P=0.018) and postnatal surfactants were required more frequently in the control group (P=0.02). CONCLUSION: Intra-amniotic administration of surfactants reduced RDS severity and the need for postpartum endotracheal surfactants. Clinical Trials Registry India: CTRI/2015/12/006399.


Assuntos
Nascimento Prematuro/tratamento farmacológico , Surfactantes Pulmonares/administração & dosagem , Síndrome do Desconforto Respiratório do Recém-Nascido/prevenção & controle , Adulto , Âmnio , Parto Obstétrico , Feminino , Humanos , Incidência , Índia , Injeções , Pessoa de Meia-Idade , Projetos Piloto , Gravidez , Resultado da Gravidez , Estudos Prospectivos , Índice de Gravidade de Doença , Ultrassonografia , Adulto Jovem
7.
J Forensic Leg Med ; 18(7): 302-5, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21907932

RESUMO

The pore characteristics on the epidermal friction ridges are individualistic and thereby useful in the process of identification when used along with other minutiae details. The present work was undertaken with the objective of studying the sex difference and influence of age on the pore morphology. The study included 230 Indians belonging to various age groups. There was no significant difference in the pore characteristics between both the sexes. The average number of pores per centimeter of friction ridge was 8.40 in males and 8.83 in females. The closed type was the commonest type of pores seen. The size of pores varied from 69 µm to 284 µm in males and 66 µm-287 µm in females. The medium-sized pores were more common than the small and large-sized pores. The majority of the pores were situated in the periphery of the ridge. The commonest shape of pores seen was circular and oval shaped pores. As the age advances, the number of pores does not significantly vary. But, the size gradually increases, and the position and shape of pores changes with the age.


Assuntos
Dermatoglifia , Epiderme/ultraestrutura , Adolescente , Adulto , Fatores Etários , Idoso , Criança , Pré-Escolar , Feminino , Humanos , Índia , Masculino , Microscopia , Pessoa de Meia-Idade , Caracteres Sexuais , População Branca , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...